Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Gastrointestin Liver Dis ; 25(4): 489-497, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27981305

ABSTRACT

BACKGROUND AND AIMS: Hepatic encephalopathy (HE) is a serious neuropsychiatric sequela emerging in the advanced stages of cirrhosis. The gut microbiota plays an important role in the development of HE. The aim of the study was to analyze the dynamic interplay between microbiota and Blastocystis in cirrhotic patients with or without encephalopathy. METHODS: The study was designed as cross-sectional study. A total of 37 patients from the Ankara city, admitted to the University Hospital within a 6-month period prior to enrolment into the study were included in the study. After the regular health checks, clinical histories, clinical examinations, and Psychometric HE Score (PHES) points, patients' MELD and CTP scores were recorded. The fecal microbiota configurations were characterized by targeting hypervariable regions V3 and V4 of the 16S rRNA gene using Illumina MiSeq System. RESULTS: Blastocystis spp. were detected in 21.6% (n = 8) of all cirrhotic patients. When those were analyzed by subgroups, four of them were subtype 2, three were subtype 3 and one was subtype 1. Blastocystis spp. were not found in any of the patients with HE; however, they were detected in 38.1% of the patients without HE. Also the increase in the bacterial diversity was observed along with the absence of Blastocystis. It was suggested that there was an inverse relationship between Blastocystis spp. and advanced stages of HE and the structure and composition of gut microbiota. CONCLUSION: The absence of Blastocystis spp. is associated with the HE severity and dysbiosis in the gut microbiota.


Subject(s)
Bacteria/isolation & purification , Blastocystis Infections/parasitology , Blastocystis/isolation & purification , Gastrointestinal Microbiome , Gastrointestinal Tract/microbiology , Gastrointestinal Tract/parasitology , Hepatic Encephalopathy/microbiology , Hepatic Encephalopathy/parasitology , Liver Cirrhosis/microbiology , Liver Cirrhosis/parasitology , Adult , Aged , Aged, 80 and over , Bacteria/classification , Bacteria/genetics , Blastocystis/classification , Blastocystis/genetics , Blastocystis Infections/diagnosis , Blastocystis Infections/epidemiology , Cross-Sectional Studies , Dysbiosis , Feces/microbiology , Feces/parasitology , Female , Hepatic Encephalopathy/diagnosis , Hepatic Encephalopathy/epidemiology , Hospitals, University , Host-Pathogen Interactions , Humans , Liver Cirrhosis/diagnosis , Liver Cirrhosis/epidemiology , Male , Middle Aged , Prevalence , Ribotyping , Turkey/epidemiology , Young Adult
2.
BMJ Case Rep ; 20162016 Aug 02.
Article in English | MEDLINE | ID: mdl-27485874

ABSTRACT

This is a case report of a 24-year-old Ethiopian woman with a medical history of hepatosplenic schistosomiasis. She suffers from chronic liver failure and portal hypertension. She has been hospitalised for 'hysteria' in the past but did not receive follow-up, outpatient treatment or psychiatric evaluation. After discontinuing her medications and leaving her family to use holy water, a religious medicine used by many Ethiopians, she was found at a nearby monastery. She was non-communicative and difficult to arouse. The patient was rushed to nearby University of Gondar Hospital where she received treatment for hepatic encephalopathy and spontaneous bacterial peritonitis. Her illness is the result of neglected tropical disease, reliance on traditional medicine as opposed to biomedical services and the poor state of psychiatric care in the developing world.


Subject(s)
Developing Countries , Hepatic Encephalopathy/parasitology , Liver Diseases, Parasitic/complications , Medicine, African Traditional/adverse effects , Schistosomiasis/complications , Splenic Diseases/complications , End Stage Liver Disease/parasitology , Ethiopia , Female , Humans , Hypertension, Portal/parasitology , Hysteria/parasitology , Liver Diseases, Parasitic/parasitology , Liver Diseases, Parasitic/psychology , Liver Diseases, Parasitic/therapy , Medicine, African Traditional/methods , Peritonitis/microbiology , Schistosomiasis/psychology , Schistosomiasis/therapy , Splenic Diseases/parasitology , Splenic Diseases/therapy , Young Adult
3.
QJM ; 96(7): 505-12, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12881593

ABSTRACT

BACKGROUND: According to the WHO, signs of hepatic dysfunction are unusual, and hepatic encephalopathy is never seen in malaria. However, in recent years, isolated cases have been reported from different parts of world. AIM: To identify the evidence for hepatocyte dysfunction and/or encephalopathy in jaundiced patients with falciparum malaria. DESIGN: Prospective observational study. METHODS: We studied 86 adult patients of both sexes who had malaria with jaundice (serum bilirubin > 3 mg%). The main outcome measures were: flapping tremor, deranged psychometric test, level of consciousness, serum bilirubin level, serum aspartate transaminase (AST) and alanine transaminase (ALT) levels, blood ammonia level, viral markers for hepatitis, ultrasonography of liver and gall bladder and electroencephalography (EEG). RESULTS: The range of serum bilirubin was 3-48.2 mg% (mean +/- SD 10.44 +/- 8.71 mg%). The ranges of AST and ALT levels were 40-1120 IU/l (294.47 +/- 250.67 IU/l) and 40-1245 IU/l (371.12 +/- 296.76 IU/l), respectively. Evidence of hepatic encephalopathy was seen in 15 patients. Asterexis was observed in 9 patients, impaired psychometric tests in 12 and altered mental state in 13. Arterial blood ammonia level was 120-427 meq/l (310 +/- 98.39 meq/l). EEG findings included presence of large bilateral synchronous slow waves, pseudo burst suppression and triphasic waves. Four patients died due to multiple organ dysfunction; the others made rapid recoveries. DISCUSSION: There is strong evidence of hepatocyte dysfunction and hepatic encephalopathy in some of these patients, with no obvious non-malarial explanation. Current guidelines may need to be revised.


Subject(s)
Hepatic Encephalopathy/parasitology , Hepatocytes/parasitology , Liver Diseases, Parasitic/complications , Malaria, Falciparum/complications , Adult , Alanine Transaminase/blood , Antimalarials/therapeutic use , Aspartate Aminotransferases/blood , Bilirubin/blood , Biomarkers/blood , Female , Hepatic Encephalopathy/drug therapy , Humans , Jaundice/drug therapy , Jaundice/parasitology , Liver Diseases, Parasitic/diagnosis , Liver Diseases, Parasitic/drug therapy , Malaria, Falciparum/drug therapy , Male , Prospective Studies , Quinine/therapeutic use , Treatment Outcome
7.
Wien Med Wochenschr ; 129(11): 301-3, 1979 Jun 10.
Article in German | MEDLINE | ID: mdl-380183

ABSTRACT

After arriving in Austria a 10 month old Nigerian infant fell sick with malaria tropica and survived after specific antiparasitic therapy. Early diagnosis and immediate begin of treatment are stressed.


Subject(s)
Hepatic Encephalopathy/etiology , Malaria/complications , Austria , Erythrocytes/parasitology , Female , Hepatic Encephalopathy/parasitology , Humans , Infant , Nigeria/ethnology , Plasmodium falciparum/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...